Alentis Therapeutics AG
Developing Claudin-1 antibodies for cancer and fibrosis
Read more
These startups have grown into industry leaders and global ambassadors for Swiss innovation. Their success shows how international ambition and early exposure to top ecosystems can drive real impact.
Discover the Venture Leaders alumni who are shaping industries and proving what Swiss founders can achieve globally.
Developing Claudin-1 antibodies for cancer and fibrosis
Read more
Cancer vaccines
Read more
Building tomorrow's antibody-drug conjugates (ADCs)
Read more
Superior products from natural fibers
Read more
Empowering entire workforces
Read more
New standard in multiplexed protein quantification
Read more
Saving lives in resistant times.
Read more
Capturing CO2 from air
Read more